MS frontiers 2013 brochure

  • View

  • Download

Embed Size (px)



Text of MS frontiers 2013 brochure

  • 1. Sofitel London, Heathrow 9-10 May 2013MSFrontiers2013Bringingthe researchcommunitytogether tobeat MSIn association with12 CPD points availableVisit: download the free web app now.MS_FrontiersHandbook_2013v2withSash.indd 1 25/04/2013 11:24
  • 2. Name Client Name Job Number Filename PublicationIssue Date Materials Due Date Ad Bleed Size Ad Trim Size Ad Live Area SizeInnovating healthcare, improving health.At Novartis, our goal is to provide high-quality healthcaresolutions to address the evolving needs of patients and societyin the UK. We believe that our dedication to innovation andour responsible approach will enable us to fulfill our missionto care for, and provide high quality treatments for, peoplewith Multiple Sclerosis. Novartis is committed to playing apart in supporting those who are affected by the condition.MUL13-C015Date of Preparation April 2013MS_FrontiersHandbook_2013v2withSash.indd 2 25/04/2013 11:24
  • 3. MS Frontiers programmeContents3. Contents 4. Welcome 5. Conference Programme9. Biographies16. Presentation abstracts29. Poster abstracts83. Notes87. Sponsor information3MS_FrontiersHandbook_2013v2withSash.indd 3 25/04/2013 11:24
  • 4. 4WelcomeWelcome to MSFrontiers 2013.I was delighted to accept the position of Acting CEO in February, notleast because it has allowed me to see at first hand the dedication andcommitment the research community shows to people affected by MSand the MS Society.At the MS Society we value research because we can see the differenceit makes to people with MS. But we want to make sure that theresearch we fund will have the greatest impact on the lives of thoseaffected by MS. To that end, weve launched a new research strategy(running from 2013 to the end of 2017).The strategy was developed in consultation with the research community and people affected byMS. It sets out our priorities for the next five years and outlines where we are with MS research aswell as highlights areas that need focussed attention, such as progressive MS. You can read thestrategy on our website or we have a limited number of copies available atour Information Stand.In parallel to the strategy we are also running a priority setting partnership with the James LindAlliance, Association of British Neurologists, UK MS Nurses Association and the MS TherapyCentres. This partnership will enable people affected by MS and health care professionals to setresearch priorities to funders.The aim will be to come up with a top 10 list of research questions that reflect the needs of peoplewith MS. Following a survey which closed in January, we have developed a long-list of researchquestions that people are now free to vote on. If youd like to find out more about this importantproject and vote on your research priorities please visit our poster for more information.Finally, I hope this MS Frontiers gives you the opportunity to network, learn about the latestfindings in MS research and share your work. We look forward to working with you in years tocome to ultimately reach our aim: To Beat MS.It is an exciting time for MS research with new treatments coming through and new breakthroughson the horizon and I feel privileged to be a part of that. Can I take this opportunity to thank you foryour help, support and interest which is greatly appreciated.With best wishes,PatriciaPatricia GordonActing Chief ExecutiveMS SocietyMS_FrontiersHandbook_2013v2withSash.indd 4 25/04/2013 11:24
  • 5. 5Conference programmeThursday 9 May09:30-10:30 Registration & refreshments10:30-10:50Opening address Patricia Gordon, Acting Chief Executive, MS SocietyProf. Sir Andy Haines, London School of Hygiene and Tropical Medicine and co-chair of the MS Society Research Strategy Committee10:50-12:30Inflammation and axonal damage:protective vs detrimental mechanismsProf. Frauke Zipp, Department of Neurology, JohannesGutenberg University Medical Centre MainzPragmatic Exercise Intervention for People with MS:the ExIMS trialProf. John Saxton, School of Allied Health Professions,University of East AngliaSession chaired by Nick Rijke, Director of Policy andResearch, MS Society12:30-13:30Lunch13:30-15:30 Parallel sessions A. Mechanisms of axonal damageChair: Prof Hugh Perry, University of Southampton Invited Speakers: Dr Don Mahad, University of Edinburgh Dr Michael Coleman, The Babraham Institute Prof Sandra Amor, VU University Medical Center B. Risk factors of MSChair: Prof Gavin Giovannoni, Barts and the London NHS TrustInvited Speakers: Dr Ian Galea, University of Southampton Dr Ruth Dobson, Barts and the London School of Medicine Dr Robyn Lucas, The Australian National University C. Exercise and Physical Activity for People with MSChair: Dr Lorna Paul, University of Glasgow Invited Speakers: Prof Mathias Maurer, University Hospital Erlangen Dr Ulrik Dalgas, Aarhus University Prof Helen Dawes, Oxford Brookes UniversityMS_FrontiersHandbook_2013v2withSash.indd 5 25/04/2013 11:24
  • 6. 6Conference programme15:30-17:30 Poster session with refreshments17:30-18:30 Debate sessionThere is compelling evidence that early aggressivetreatment of MS leads to long-term benefits for thepatient and this should be considered the norm inclinical practice Chair: Dr Raj Kapoor, National Hospital of Neurology andNeurosurgery, Queen Square, LondonFor the motion: Prof. Gavin Giovannoni, Barts and the London NHS TrustAgainst the motion: Dr Nikos Evangelou, Queens MedicalCentre, Nottingham Hospitals NHS Trust19:00-20:00 Drinks reception20:00 Conference dinnerMS_FrontiersHandbook_2013v2withSash.indd 6 25/04/2013 11:24
  • 7. 7Conference programmeFriday 10 May09:00-09:30 Registration & refreshments09:30-11:30 Parallel sessionsA. Biomarkers and clinical outcome measures:challenges for progressive MS trials Chair: Dr Raj Kapoor, National Hospital of Neurologyand Neurosurgery, Queen Square, London Invited speakers: Prof Richard Ruddick, Cleveland ClinicProf David Miller, National Hospital for Neurology andNeurosurgery Prof Gavin Giovannoni, Barts and the London School of DentistryB. Mind and body: The interface betweenpsychological and biomedical in MS Chair: Prof Roger Baker, Bournemouth University Invited speakers: Prof Trudie Chalder, Kings College London Prof Rona Moss-Morris, Kings College London Mr Stuart Nixon, Person with MS and MS Society TrusteeC. Innovations in symptom management,care and supportChair: Dr Richard Warner, Gloucestershire Hospitals NHS Foundation Trust Invited speakers: Dr Rosie Jones, Frenchay Hospital Prof. Jon Marsden, University of Plymouth Prof. James Malone-Lee, University College London11:30-11:45Refreshments11:45-13:30Strategies for target discovery to promoteremyelination Prof Charles ffrench-Constant, University of EdinburghAchievements of the MS Register in the firstthree years and future plans Prof. David Ford, University of Swansea Session chaired by JOHN MILLER, MS Society Trustee13:30-14:30LunchMS_FrontiersHandbook_2013v2withSash.indd 7 25/04/2013 11:24
  • 8. 8Conference programme14:30-15:30 Ian McDonald Memorial LectureMechanisms of tissue injury in Multiple Sclerosis:Lessons for understanding progressive MS Prof Hans Lassmann Center for Brain Research, Medical University of Vienna, AustriaSession chaired by Prof. Richard Reynolds, Imperial CollegeLondon15:30-15:45 Close of conferenceMS_FrontiersHandbook_2013v2withSash.indd 8 25/04/2013 11:24
  • 9. 9BiographiesSpeaker biographiesFrauke Zipp - After studying Medicine in Germany, the USA, Canada and England, Frauke Zipp beganher scientific career at the MPI Martinsried with Hartmut Wekerle in Neuroimmunology. During clinicaltraining with Johannes Dichgans in Tbingen, she was a visiting scientist at the NIH. After a decade atthe Charit, she moved to the Rhine Main Neuroscience Network (rmn2) as Director of the Departmentof Neurology at the University Medical Center Mainz within the Focus Program of TranslationalNeurosciences. She is currently spokesperson of a Collaborative Research Center on Multiple Sclerosis, oneCo-Coordinator of the Competence Network of Multiple Sclerosis, a Council Member of ECTRIMS and aBoard Member of ISNI. In 2014, she will be a chair of the ISNI conference taking place in Mainz (rmn2).John Saxton is a Professor of Clinical Exercise Physiology in the Faculty of Medicine and HealthSciences at the University of East Anglia, Norwich. He is a BASES Accredited Research Physiologist,member of the Physiological Society and has served on Council for the Society for Research inRehabilitation. His research is focused on the role of exercise and other lifestyle factors in the preventionand management of age-related chronic conditions. He has worked with a number of clinical populations,including people with MS, cancer patients and survivors, patients with peripheral vascular disease andchronic heart failure. His research has been funded by the MS Society, the British Heart Foundation,Heart Research UK, Cancer Research UK and the American Institute for Cancer Research. In 2011 hewas the editor of a book entitled Exercise and chronic disease: an evidence-based approach, publishedby Routledge, UK.Hugh Perry was appointed Professor of Experimental Neuropathol